Measuring What Matters: PROMs in Urticaria Care
All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten ZuberbierShow Notes
In this episode of the GA²LEN (Global Allergy and Asthma Excellence Network) Podcast on Everything Urticaria, Professor Torsten Zuberbier talks with Dr. Karsten Weller, a leading expert and developer of patient-reported outcome measures (PROMs), about how these tools are transforming the management of urticaria and angioedema in both research and daily care.
The discuss: 🔹 What are PROMs and why are they essential in urticaria management? 🔹 How are they developed and validated scientifically? 🔹 Which tools should clinicians use in everyday practice? 🔹 What does the future hold for digital and app-based patient assessment? Dr. Weller explains how PROMs such as the Urticaria Control Test (UCT) help physicians understand disease control directly from the patient’s perspective. He discusses the scientific process of developing and validating PROMs, the benefits of integrating them into digital tools like the CRUSE App, and how simple, standardized communication enhances care. Together, they explore the future of patient-centered assessment, from wearable technologies to the evolving language of quality-of-life measures.
Key Learnings from the Episode: PROMs capture the patient’s own perception of disease activity, control, and quality of life—crucial for fluctuating conditions like urticaria. The Urticaria Control Test (UCT) is a quick, validated 4-question tool recommended for every patient visit. PROM development follows a rigorous process including patient input, expert review, and validation studies. Tools like the Chronic Urticaria QoL Questionnaire (CU-Q2oL) and Angioedema QoL Questionnaire (AE-QoL) add depth when time allows. Digital apps such as the CRUSE App integrate PROMs into daily life and facilitate doctor–patient communication. Despite new technologies, the patient’s direct voice remains irreplaceable in capturing holistic well-being. The language of questionnaires must be periodically reviewed to stay clear and relevant across generations. PROMs promote standardized, efficient, and patient-centered care, empowering better decisions and stronger engagement.
Chapters 00:00 Introduction to Patient-Reported Outcome Measures (PROMs) 03:23 The Development Process of PROMs 05:57 Practical Application of PROMs in Clinical Practice 08:40 The Future of Digital Tools in Patient Care 11:28 Language and Communication in Patient-Reported Outcomes 14:10 Final Thoughts and Conclusion
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Feedback form: ATU: https://forms.office.com/e/m6a2uEdsUH
More from All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier
In this episode of the UCARE Global Allergy and Asthma Excellence Network podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Angelo Valerio Marzano from Milan about urticarial vasculitis and its challenging differential diagnoses. They explore how clinicians can distinguish urticarial vasculitis from chronic urticaria and other dermatological or systemic conditions and discuss practical approaches to diagnosis and treatment.
In this episode of the Global Allergy and Asthma Excellence Network UCARE Podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Marta Ferrer from Spain about an important question: Is chronic spontaneous urticaria (CSU) only a skin disease, or is it a systemic inflammatory condition? Together, they discuss emerging evidence showing that urticaria affects far more than the skin and how this should influence patient management.
In this episode of the UCARE Global Allergy and Asthma Excellence Network (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Akio Tanaka from Hiroshima University, Japan, about an important question many patients ask: how long will chronic urticaria last, and can treatment influence the course of the disease? They discuss disease modification, symptom control, and future research directions in urticaria management.
In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Hermenio Lima discuss the growing role of artificial intelligence (AI) in medicine and how it may influence urticaria care, research, and patient management in the future.
In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Maia Gotua discuss the role of infections in acute and chronic urticaria. They explore how infections can trigger, mimic, or worsen symptoms—and why careful clinical evaluation is key.